EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹0.00 Cr | ₹-0.38 Cr | ₹-1.01 Cr | ₹-0.34 Cr | ₹0.04 Cr |
What is the latest Net Cash Inflow / Outflow ratio of EVEREST ORGANICS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹0.00 Cr |
Mar2023 | ₹-0.38 Cr |
Mar2022 | ₹-1.01 Cr |
Mar2021 | ₹-0.34 Cr |
Mar2020 | ₹0.04 Cr |
How is Net Cash Inflow / Outflow of EVEREST ORGANICS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹0.00 Cr | Negative | |
Mar2023 | ₹-0.38 Cr | Negative | |
Mar2022 | ₹-1.01 Cr | Negative | |
Mar2021 | ₹-0.34 Cr | Negative | |
Mar2020 | ₹0.04 Cr | - |
Compare Net Cash Inflow / Outflow of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹382.8 Cr | -4.3% | 18.1% | 193.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | -4.3% |
18.1% |
193.2% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses